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Abstract
The appearance of a new coronavirus disease called COVID-19 at the end of 
2019 and its pandemic expansion in the world has changed the usual practice of 
medicine, and has had great impact in the field of Otorhinolaryngology and Head 
and Neck Surgery (OHNS). The aim of this document is to review the available 
evidence and propose strategies and recommendations for the medical-surgical 
practice of OHNS, which allow establishing the usual activity, adapting the safety 
and efficacy standards to the current pandemic situation. Therefore, it is required 
to identify and classify patients according to criteria of infectious-immunological 
status, and to establish recommendations for protection in consultations, hospital-
ization and the operating room, which avoid the transmission of the disease to other 
users and healthcare personnel, in the specific context of the development of our 
specialty. This document is the result of the collaboration of all the scientific com-
missions of Spanish OHNS society and therefore might help other OHNS to develop 
their work during COVID-19 pandemic.
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1. Introduction
The SARS CoV-2 disease (COVID-19) has caused millions of deaths worldwide 
since the pandemic status was declared by the World Health Organization (WHO) 
in March 2020 [1]. The SARS-CoV-2 virus, whose origin is suspected to be associ-
ated with bats or peanuts [2], is a single-stranded RNA-virus of the Coronaviridae 
family, closely related to the viruses responsible for severe acute respiratory syn-
drome (SARS) and Middle East respiratory syndrome (MERS). The main routes 
of entry of the virus are the mucosae of the oral and nasal cavities. Transmission 
occurs through direct contact from contaminated hands, fomites, or through 
airborne aerosols expelled when coughing, sneezing, screaming, singing, speaking, 
or breathing [3, 4]. The incubation period varies between 2 and 14 days (5.7 days 
on average) [5], after which the patient may be asymptomatic [6] or may manifest 
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symptoms including fever, dry cough, dyspnea, myalgia, fatigue, headache, diar-
rhea, general malaise, anosmia, hyposmia and dysgeusia. The disease course is usu-
ally limited, although it can progress to bilateral pneumonia, respiratory distress, 
and death. The fatality rate of the disease is estimated to be 0.68% [7] but highly 
dependent on age and concurrent risk factors [8].
One of the greatest difficulties in controlling the disease is the possibility 
of transmission of the etiological agent by asymptomatic and presymptomatic 
patients. Still, the transmissibility of COVID-19 likely correlates with the onset of 
symptoms, with the risk lower and the lowest in presymptomatic and asymptomatic 
patients, respectively [9].
Health workers represent a significant percentage of the general population 
infected [10]. Among physicians, otorhinolaryngologists and head and neck 
surgeons may be at an even greater risk as a result of their frequent proximity to the 
upper airway and the generation of bioaerosols in their procedures [11, 12]. In fact, 
the infection rate of Spanish otorhinolaryngologists rose to 16.5% during the first 
two waves [13]. As is such, the objective of this chapter is to provide a consensus 
on the management of head and neck patients during the COVID-19 era based on a 
compilation of the best evidence adapted to the risk of transmission [14, 15].
2. Diagnosis and screening of COVID-19 patients
2.1 Diagnosis
1. Presence of the virus
a. Detection of viral RNA: Using reverse transcriptase and polymerase chain 
reaction (RT-PCR), the presence of specific genes of the SARS-CoV-2 virus 
is determined in samples from different areas of the airway. In patients with 
asymptomatic, presymptomatic, or mild forms of presentation, positive 
RT-PCR does not necessarily confirm nor disprove transmissiblity. RT qPCR, a 
subtype of RT-PCR, provides a quantitative estimate by means of fluorescence 
that increases proportionally to the amount of nucleic acid amplified. This test 
reports the viral load present in the sample by detecting a specified threshold 
in a certain number of cycles (Ct or cycle threshold) in RT-PCR [16, 17].
b. Presence of virus antigens (S, M and E antigens) in airway secretions: While 
accessible, this test shows a high number of false negatives depending on the 
patient’s current stage of the disease. This rapid viral antigen detection test 
may still be effective in symptomatic patients in the outpatient setting or in 
large population screenings. It is highly sensitive in patients with symptoms 
of disease and with less than 5 days of disease progression. Despite this high 
sensitivity, a negative test does not confirm an absence of disease especially 
if suspicious symptoms are present, at which point an RT-PCR test is recom-
mended [18].
2. Detection of antibodies in serum: In severe COVID-19 patients at least 7 days 
since the onset of symptoms, the detection of IgM antibodies has been consid-
ered a sign of the patient’s immune response [19]. Up to 20% of patients with 
mild forms of COVID-19 do not produce detectoble serum antibodies [17, 20]. 
Production of the longer-lasting IgG antibodies begin approximately 14 days 
after the onset of symptoms and may incur long-term immunity to disease. 
IgM or IgG antibodies may have some value in the diagnosis of patients with 
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negative RT-PCR results but with continued COVID-19 symptoms since the 
seroconversion of specific IgM and IgG antibodies have been detected as early 
as the 4th day after the onset of symptoms
The antibody study can be performed by:
a. Rapid antibody detection tests, which are based on immunochromatography 
(lateral flow technique) and have become popular as “rapid tests” for anti-
body detection [20]. The Spanish Society of Immunology recommends its use 
for epidemiological studies in high risk groups [21].
b. Laboratory tests to measure the level of antibodies, which use enzyme-
linked immunosorbent assay (ELISA) or chemiluminescence assay (CLIA). 
They are quantitative tests (specifically, CLIA has a sensitivity of 1 pg./ml 
in serum), and have higher sensitivity and specificity. They are standard-
ized and easily interpreted, but require specialized personnel to perform 
them [21].
2.2 Interpretation of the diagnostic tests
The gold standard in detecting viral infection is RT-PCR since its diagnostic 
precision is superior to the tests that detect the presence of the viral capsid antigens. 
SARS-CoV-2 antibody tests do not predict viral shedding and cannot be used to 
rule out risk of transmission. Rapid tests, both for antigens and antibodies, should 
be used for screening purposes only when (1) monitoring progression of a known 
positive case, or (2) when there is a very low suspicion of disease.
The presence of antibodies in COVID-19 patients should always be inter-
preted taking into account the result of the RT-PCR and the clinical phase of the 
disease. The levels of IgM and IgG antibodies could indicate host response to the 
virus [22].
Antibody seroprevalence levels of the general population – of those who have 
not suffered from the disease, or those who have only experienced its mild forms, 
− are needed in order to ascertain the significance of the antibodies, if the immune 
response is really protective, and how long this protection lasts [17].
2.3 Transmissibility and completion of isolation
The duration of transmissibility varies among patients with nondetectable, 
asymptomatic, mild, and severe symptoms. In general, there is evidence that virus 
transmission does not occur after the ninth asymptomatic day [23], although in 
severe cases, this point can be difficult to establish as residual symptoms may 
last longer.
In the general population, a negative RT-PCR is not considered sufficient to 
rule out transmissibility and the patient may require continued quarantine. The 
lack of replicable viral genetic material in the nasopharynx is a good indicator but 
not an absolute marker against transmissibility [24]. In asymptomatic patients 
isolated at home, the confinement may be terminated 10 days after a negative 
RT-PCR test. In symptomatic patients, the duration of the confinement should be 
10 days from the resolution of symptoms including fever. Patients with severe or 
life-threatening symptoms may require an isolation duration of 21 days. The rec-
ommendations for healthcare personnel are different and at least one diagnostic 
test – either IgG or RT-PCR - should be performed prior to the end of the isolation 
period [15].
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2.4  General screening of ENT patients who are candidates for surgery or 
invasive upper airway exploration
During the pandemic, head and neck clinicians should screen for active 
SARS-CoV-2 infection in all patients who are to undergo consultation, invasive 
examination, or ENT surgery. The choice of tests may vary according to the scale of 
coordinated response published by the region’s healthcare governing body such as 
the Ministry of Health and Consumption and Social Welfare of the Government of 
Spain (MSCBS) [25].
Pre-operative screening should be performed by health or social-health person-
nel to all patients sufficiently in advance and, when possible, without face-to-face 
contact. The microbiological and immunological screening should entail RT-PCR 
ideally within 72 hours of procedure, followed by patient isolation to prevent subse-
quent infection. The screening should not be based on antigen testing [12].
Specific screening protocols depend on the specific alert scenario of the ter-
ritory. In Spain, the following was recommended for the screening of active 
infections:
1. In Alert Level 2 or higher scenarios with unfavorable epidemiology, complete 
pre-surgical screening should be performed since both the patient and surgery 
are considered high risk (Table 1) (Figure 1).
2. If the epidemiology of the health area or territory is favorable (Alert Level 1), 
and with intermediate patient and surgery risks, RT-PCR could be replaced 
with “rapid” antigen testing (Table 1) (Figure 2).
3. If the epidemiology of the health area or territory is favorable (Alert  
Level 1), and with intermediate patient risk and low risk surgery, screening 
may be simplified (Table 1) (Figure 2).
In cases where surgery has been suspended, patients should be re-considered 
for surgery based on an asymptomatic period of at least 10 days. If symptoms or 
other suspicions persist, a repeat test should be undertaken within 72 hours prior to 
surgery. Both inpatients as well as outpatients scheduled for elective surgery should 
follow the same screening process and undergo repeat testing as indicated whether 
or not it was performed previously.
Additionally, patients with documented resolved infection in the last 3 months 
with an absence of symptoms and Alert Level 1 or lower epidemiology of the area 
likely do not require repeat RT-PCR testing. Nonetheless, the surgeon should review 
all risks and consider a delay of up to 4 weeks from the onset of symptoms [15].
The exact risks of treating vaccinated patients have not yet been well estab-
lished. At this time, the authors recommend that all patients be treated with the 
same basic precautions afforded the non-immunized patients until further data 
becomes available.
2.5  Non-surgical protection measures for otolaryngologists and head and neck 
surgeons
The use of Personal Protective Equipment (PPE) should be mandatory regard-
less of the regional epidemiology until normality of care is reintroduced. Along 
with the basic precautions including appropriate work attire and disposable surgi-
cal masks, three degrees of precautions against airborne transmission have been 




































Indicators Estimate Risk assessment
New 
normality
Low Medium High Very 
high
BLOCK I: Evaluation of the transmission level.
T1 Cumulative incidence of cases diagnosed 
in 14 days.
Confirmed cases (by diagnosis date) in 14 days *100,000/
number of inhabitants.







T1’ Cumulative incidence of cases diagnosed 
in 7 days.
Confirmed cases (by diagnosis date) in 7 days *100,000/
number of inhabitants.
≤10 >10 to 
≤25
>25 to ≤75 >75 to 
≤125
>125
T2 Cumulative incidence of cases 
aged ≥ 65 years diagnosed in 14 days.
Confirmed cases ≥ 65 years (by date of diagnosis) in 14 days 
*100,000/number of inhabitants > 65 years.







T2’ Cumulative incidence of cases 
aged ≥ 65 years diagnosed in 7 days.
Confirmed cases ≥ 65 years (by date of diagnosis) in 7 days 
*100,000/number of inhabitants ≥ 65 years.
≤10 >10 to 
≤25
>25 to ≤50 >50 to 
≤75
>75
T3 Global positivity of diagnostic tests for 
active infection (PDIA) per week.
N° of tests with a positive result in 7 days *100/N° of tests 
carried out in 7 days.







T4 Percentage of cases with traceability. N° of cases diagnosed with traceability *100/Total N° of 
confirmed cases diagnosed in the last 7 days.







BLOCK II: Level of use of healthcare services due to COVID-19
A1 Occupancy of hospital beds due to 
COVID-19 cases
N° of hospital beds occupied by COVID cases/Total hospital 
beds in operation.







A2 Occupancy of critical care beds due to 
COVID-19 cases
N° of critical care beds occupied by COVID cases/Total N° of 
total critical care beds in operation.








Indicators for risk assessment for COVID-19 [25]. Alert level 1: When at least two indicators from Block I and one from Block II are low; alert level 2: When at least two indicators from Block I 
and one from Block II are at medium level; alert level 3: When at least two indicators from Block I and one from Block II are at a high level; alert level 4: When at least two indicators from Block I 
and one from Block II are at a very high level.
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Figure 1. 
Screening of the ENT patient at alert levels 2 or higher of the COVID-19 pandemic.
Figure 2. 
Screening of the ENT patient at alert level 1 or lower during the COVID-19 pandemic.
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In patients with hearing loss, tspecialized masks for lip reading can be used as 
long as there are no undo risks for the healthcare professional, such as the produc-
tion of excess aerosols. [28, 29]. Hand washing and disinfection with hydroalcoholic 
gels should be conducted consistently based on WHO recommendations. [30, 31].
Relevant information regarding treatment policies should be accessible. Such 
information could be displayed either physically (posters, brochures, etc.) or online 
(websites and apps). They should include patient and provider expections such as 
the use of face-masks, social distancing, and hand hygiene [32], as well as info-
graphics on loud verbalizations which could produce large amounts of projectile 
aerosols [33]. These spaces must be adapted with hydroalcoholic solution dispens-
ers, waste containers with pedal-operated lid, as well as properly separated and 
indicated seats that help maintain a safe distance between people.
Waiting rooms should be modified so that patients are able to keep 2 meters 
between them (Figure 3). If the structure of the rooms make social distancing 
difficult, multiple waiting areas should be made available such that each area houses 
no more than three patients and companions.
Telemedicine is recommended whenever possible as it allows for safe consulta-
tion and helps prevent delays in care [34]. If the patient requires a face-to-face 
consultation, a prior clinical screening (preferably conducted remotely) is recom-
mended. Again, waiting rooms should be modified so that patients can keep a 
distance 2 meters. Unnecessary fixtures and decorations should also be eliminated 
from the consultation area to facilitate movement of patients as well as medical 
equipment and to aid in subsequent disinfection [12, 26]. During consultation the 
door must remain closed with the air circulation for at least 15 minutes after each 
consult, especially at Alert Levels 2 or higher. HEPA (High Efficiency Particulate 
Air) filters, capable of filtering at least 99.97% of particles with a diameter greater 
than or equal to 0.3 μm in one cycle, should be utilized during disinfection of the 
consultation spaces [35].
The use of 0.5% povidone-iodine (PVP-I) in oral rinses and nasal drops could be 
used to decrease the local concentrations of the virus [36, 37], although there is no 
definite evidence that this measure reduces transmissibility and can lead to a false 
sense of security [38].
Specific precautionary measures have been outlined for non-surgical procedures 
in ENT in consultation and during hospital admission to the ward (Table 3).
Grade 1 Grade 2 Grade 3












Mask Surgical mask N95/FFP2 FFP3
Protective coat Not isolating Isolation gown Isolation gown
Gloves Latex or equivalent. Latex or equivalent Latex or equivalent
Footwear Not covered Covered Covered








Individual precautions depending on the gradation of the risk of contagion [27].
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Audiometry tests are conducted in closed spaces that may be difficult to disin-
fect. Additional precautions must be taken during these examinations. Both the 
patient and the auxiliary personnel must each enter with a mask and should protect 
the surfaces they touch with proper hand hygiene and glove usage. The patient 
should be instructed to avoid touching surfaces other than the chair, and the tests 
themselves should be done via recording (Table 4).
Once the patient departs, the disposable materials must be disposed in their 
respective recepticles, and the contact surfaces disinfected using disposable anti-
microbial cleaners. Many common cleaning and disinfection products are effective 
against coronaviruses, which can otherwise remain active on plastic and stainless 
steel surfaces for 2–3 days [50] and up to 9 days on other non-porous surfaces [35]. 
Among the most used cleaning agents are 0.1% sodium hypochlorite solution, 
hydroalcoholic solution, and ethanol solution (concentration of 62–71%) [43]. 
While direct investigations have not yet been conducted, studies in similar corono-
naviruses have suggested an effective eradication time after approximately 1 minute 
of contact [35].
Ultraviolet light (UV-C) may provide another method of sterilization even when 
used to decontaminate porous surfaces like masks [51]. In fact, the most efficient 
sterilization may entail a combination of both chemical and UV-C exposure [52]. 
The Spanish Society for Environmental Health (SESA) advises against the use of 
chlorine dioxide for atmospheric disinfection. Similarly, ozone disinfection requires 
a high concentration which poses risks of toxicity, requiring extended periods of 
evacuation.
3. Specific and transversal surgical measures
The prevention measures executed by the surgical team are carried out with 
the aim of protecting the team as well as the patient. The nasopharynx retains a 
relatively high viral load, and procedures in this area are associated with aerosol-
ization and dissemination of viral particles particularly during the use of drills, 
Figure 3. 
Adaptation of the waiting room respecting a safety distance of 2 meters.
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microdebridators, and/or electric or ultrasonic scalpels [11, 48, 53–55]. All patients 
planned for aerodigestive tract surgery should be screened according to the Alert 
Level of the pandemic (Figures 1 and 2). A consent form detailing the risks and 
Procedure Recommendation
Rigid or flexible endoscopy • Use of tower with camera and screen to increase the distance between 
the patient and the examiner as much as possible..
• Prevent the patient from removing the mask, but have them lower it 
partially. As an alternative, the clinician may use a system that seals the 
nose during examination.(Figure 4) [12, 39].
• Avoid unnecessary endonasal manipulations.
• Replace aerosol local anesthetics with those applied using cotton wicks 
or lenses [40, 41].
• Resorbable nasal packs should be used for acute or postsurgical 
epistaxis [11, 42].
• The removal of a nasal packing should be carried out after appropriate 
equipment measurements according to the classification of the patient 
(Table 2).
• Disinfection with phenolic compounds, peracetic acid, or sodium 
hypochlorite is prudent. As an alternative, protective covers should be 
utilized [43].
Otomicroscope • Disposable materials should be used whenever applicable.
• Barriers should be placed between the microscope and the patient such 
as methacrylate screens adapted to the binocular or disposable plastic 
covers (Figure 5).
• After examination, patient contact areas must be cleaned and disin-
fected [12, 44].
Vestibular tests • General consultation and audiometry recommendations should be 
followed (Table 4).
Hearing Screening for 
Newborns
• Each screening should be conducted by personnel who do not 
work directly with COVID19 patients, especially if the mother is 
asymptomatic.
• General patient PPEs should be utilized in all cases, and specific 
protections can be escalated according to the degree of contagion risk 
(Table 2).
• The equipment must be decontaminated after each use.
• There are some indications that children born during the COVID-19 
pandemic should be retested at the conclusion of the pandemic [45].
Post-tracheostomy care • In patients with confirmed infection, tracheostomy cuffs should remain 
inflated. In-line suction systems should be utilized and tracheostomy 
tube changes should be delayed until the RT-PCR becomes negative. 
[46, 47].
• High risk aerosol precautions should be followed even in asymptomatic 
patients.
CPAP or BiPAP devices for 
obstructive sleep apnea 
syndrome (OSA):
• Incomplete seals around the face may facilitate the risk of aerosol 
generation.
• The use of helmet-type CPAP masks is recommended to reduce the risk 
of transmission [48, 49].
Table 3. 
Specific precautionary measures during non-surgical procedures in ENT in consultation and during hospital 
admission to the ward.
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Figure 4. 
Nasal fibroendoscopy examination system. (A) Anesthesia mask. (B) Connection piece with a valve used to 
introduce the nasofibrolaryngoscope. (C) Tubing to direct the patient’s air away from the examiner. (D) Proper 
assembly.
Contagious status and severity of hearing loss
COVID-19 (−) COVID-19 (?) or COVID-19 (+)
Technical and 
material indication






Single act or delay 
audiometry
Perform audiometry on the spot (prior written or oral 
explanation facilitating the patient’s lip reading)
Delay 
Treatment
Use of soundproof 
booth
Yes According to clinical 
criteria (will be noted 
in the HC if the cabin is 
not used)
Protection of the 
patient’s face, head 
and hands
Surgical mask FFP2/KN95/N95, 




Protect the earpiece and vibrator with disposable material 
(preferably use single-use insert earphones)
Positive response 
indication






1) audiometer, 2) patient chair, 3) earpiece, 4) vibrator, 5) 
clean and air the cabin if used
Table 4. 
Carrying out audiometry; indications and protective measures for the clinician and the patient. COVID-19 
(−): Case ruled out/COVID-19 (?): Probable or suspected case/COVID-19 (+): Confirmed case [12].
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protective measures should also be presented [56], During the Alert Level 4, all 
elective surgery should be postponed [57]. Considering the large numbers of 
asymptomatic COVID cases, all patients without evidence to the contrary should 
be assumed as positive for SARS-CoV-2 and the appropriate protective measures 
should be taken [57].
A negative pressure surgical environment is recommended via a high  
frequency of air cirulation (25 circuits per hour) that reduces the viral load 
inside the operating room [58]. The same operating room and non-disposable  
anesthesia equipment is recommended for all probable or confirmed COVID-
19 patients [58, 59]. This includes urgent cases in which SARS-CoV-2 infection 
has not been ruled out. Likewise, during Alerts Level 2 or higher, the number 
of surgical team members should also be limited [41]. Endotracheal intubation 
and air-purifying respirators should be used at the time of induction [60] and 
the anesthesia must be sufficiently deep to avoid intraoperative awakening or 
coughing. The use of a closed suction system with an antiviral filter is recom-
mended [61].
Aerosolized particles of less than 5 μm can remain in suspension for more than 
3 hours, so the use of instruments that generate aerosols or particles in suspension 
(microdebriders, high-speed motors, electric or ultrasonic scalpels) should be 
avoided whenever possible [50].
Individual protection measures will be adapted according to the classification 
of the patient (Table 5). In the immediate postoperative period, and once an Alert 
Level 2 or higher is established, communication with the family members should be 
conducted electronically [72].
Figure 5. 
Microscope examination system (A) Methacrylate screen adapted to the microscope after removing the eye 
pieces. (B) Adaptation of the eye pieces to the slotted screen that allows manipulation of the interpupillary 
distance. (C) Adaptation of the eye pieces to the microscope with the methacrylate screen in place. (D) 
















Surgical individual protection measures
Infectious status of the patient
Anatomic area to protect COVID-19 (−) COVID-19 (?) COVID-19 (+)
Feet Work shoes (clogs) with disposable footwear Work shoes (clogs) with double disposable gaiter
Body (Trunk and extremities, except feet 
and hands)
Medical uniform + non-waterproof disposable surgical 
gown
Medical uniform + 
waterproof surgical gown
Medical uniform + impermeable seals between PPE 
components + waterproof surgical gown
Head (Scalp, pinna and external auditory 
canal)
Disposable surgical cap Double sterile surgical cap
Hands Simple sterile surgical glove Double sterile surgical glove
Face and neck (Forehead, neck, 
periauricular region)
Face shield (optional) Face shield Full face protective helmet or powered air-purifying 
respirators
Eyes Non-integral glasses Integral glasses Face shield + sealing goggles + impermeable covers 
for the forehead, neck, and chest
Respiratory (Mouth, nostrils and external 
auditory canal)
Surgical mask FFP3 FFP3
Specific measures during surgical or invasive procedures in ENT (Alert levels 2 or higher)
Airway management and diagnostic airway 
procedures (excluding tracheostomy) [62]
• Performed by the physician with the most experience in rapid sequence intubation techniques.
• Disposable laryngoscopes and video laryngoscopes.
• Avoid intubations with fiber optics.
• Perform airway procedures for patients with suspected, probable, or positive COVID-19 status with endotracheal intubation.
• Minimize spontaneous ventilation and repeated intubation/extubation.
Tracheostomy • Emergency tracheostomy confers a significant risk of aerosolization of the virus and should be proceeded with extreme caution [60].
• Delay elective tracheostomy, if possible, until the infected patient becomes negative.
• COVID-19 (+) tracheostomy patients should be kept in a closed circuit with inline suction.
• Delay cannula changes whenever possible until the infection resolves. If it is necessary to perform in a negative pressure room with HEPA filtra-



































Surgical individual protection measures
Infectious status of the patient
Anatomic area to protect COVID-19 (−) COVID-19 (?) COVID-19 (+)
Oral cavity, oropharynx, nasal cavity and 
nasopharynx procedures
• Postpone elective procedures involving the nasal cavity, nasopharynx, oral cavity and oropharynx in suspected, probable or positive patients 
until negative [48].
• In order to avoid admissions for post-tonsillectomy bleeding, utilize techniques with lowest risks of postoperative complications including 
bleeding (intracapsular tonsillectomy) [45, 63].
Otologic surgery • As the presence of the virus in otitis media with effusion is not ruled out [64], procedures such as transtympanic drains should be avoided [45, 
65].
• Mastoidectomy should be postponed whenever possible. If mastoidectomy is required, PPE should be worn and high-speed motors should be 
avoided [66].
Endoscopic sinonasal surgery [67, 68] • Avoid the use of microdebriders, high resolution motors, or surgical drills whenever possible.
• In case it is not possible to delay an anterior skull base intervention in a COVID-19 (+) patient, a transcranial approach could be considered in 
order to avoid sinonasal surgery, which presents a much higher risk of virus aerosolization [69]. The degree of viral involvement inf brain tissue, 
although suspected [70], appears to be much lower that of sinonasal tissues.
• Use resorbable tamponades postoperatively.
Surgery of the head and neck, and of the 
deep cervical spaces [71, 72]
• Postpone surgical excision of benign neck masses during Alert levels 2 or higher.
• Pediatric cases with solid head and neck tumors including thyroid cancer should be discussed in a multidisciplinary tumor Commission to 
decide the most appropriate treatment modality, taking into account the availability of local resources.
• Head and neck cancer patients who require surgical treatment, who have been proposed for this purpose in the relevant Commission, will have 
priority over other non-cancer procedures, regardless of the Alert Level of the pandemic.
• Whenever possible, medical treatment of infectious diseases should be attempted prior to surgical intervention.
Table 5. 
Professional protection measures in the operating room and during high risk procedures outside the operating room. COVID-19 (−): Case ruled out/ COVID-19 (?): Probable or suspected case/
COVID-19 (+): Confirmed case.
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